Lannett Launches Authorized Generic of Tirosint® (Levothyroxine Sodium Capsules)
- Tuesday, November 3, 2020, 7:05
- Finance
- Add a comment
PHILADELPHIA, Nov. 3, 2020 /PRNewswire/ — Lannett Company, Inc. (NYSE: LCI) today announced that it has commenced the launch of the authorized generic of Tirosint® (Levothyroxine Sodium Capsules USP). Lannett entered into an exclusive U.S. distribution agreement with IBSA Institut…
About the Author
adminasapcorp has written 39124 stories on this site.